Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Nicolas Leupin
Introduction
Nicolas Leupin is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of medical treatments, particularly in the area of immunology. With a total of 2 patents, his work focuses on novel methods for treating serious health conditions.
Latest Patents
One of Leupin's latest patents is titled "Use of FCRN antagonists for treatment of generalized myasthenia gravis." This patent provides innovative methods for treating generalized myasthenia gravis in subjects. The methods generally involve administering an effective amount of an isolated FcRn antagonist. Notably, the FcRn antagonist binds to FcRn with increased affinity and reduced pH dependence compared to the native Fc region.
Another significant patent is "Compositions and methods for treating immune thrombocytopenia." This patent discloses a method for treating human subjects diagnosed with immune thrombocytopenia (ITP). The method includes administering a human neonatal Fc receptor (hFcRn) antagonist, potentially in combination with standard-of-care ITP treatments. In certain embodiments, the hFcRn antagonist is efgartigimod (ARGX-113), and standard treatments may involve corticosteroids, immunosuppressants, and/or thrombopoietin receptor (TPO-R) agonists.
Career Highlights
Nicolas Leupin is associated with Argenx Bv, a company known for its innovative approaches in the field of immunology. His work at Argenx has positioned him as a key player in developing treatments that address critical health issues.
Collaborations
Leupin collaborates with notable colleagues such as Peter Ulrichts and Torsten Dreier. Their combined expertise contributes to the advancement of research and development in their field.
Conclusion
Nicolas Leupin's innovative patents and contributions to medical treatments highlight his significant role in advancing healthcare solutions. His work continues to impact the treatment of serious conditions, showcasing the importance of innovation in medicine.